These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 34399162)
41. Impulse control disorder related behaviours during long-term rotigotine treatment: a post hoc analysis. Antonini A; Chaudhuri KR; Boroojerdi B; Asgharnejad M; Bauer L; Grieger F; Weintraub D Eur J Neurol; 2016 Oct; 23(10):1556-65. PubMed ID: 27425586 [TBL] [Abstract][Full Text] [Related]
42. Impulse control disorders in Parkinson's disease: Review of pathophysiology, epidemiology, clinical features, management, and future challenges. Bhattacharjee S Neurol India; 2018; 66(4):967-975. PubMed ID: 30038082 [TBL] [Abstract][Full Text] [Related]
43. The risky business of dopamine agonists in Parkinson disease and impulse control disorders. Claassen DO; van den Wildenberg WPM; Ridderinkhof KR; Jessup CK; Harrison MB; Wooten GF; Wylie SA Behav Neurosci; 2011 Aug; 125(4):492-500. PubMed ID: 21604834 [TBL] [Abstract][Full Text] [Related]
44. Mesocorticolimbic hemodynamic response in Parkinson's disease patients with compulsive behaviors. Claassen DO; Stark AJ; Spears CA; Petersen KJ; van Wouwe NC; Kessler RM; Zald DH; Donahue MJ Mov Disord; 2017 Nov; 32(11):1574-1583. PubMed ID: 28627133 [TBL] [Abstract][Full Text] [Related]
45. Impulsive and compulsive behaviors in Parkinson's disease: a one-year follow-up study. Ávila A; Cardona X; Martín-Baranera M; Bello J; Sastre F J Neurol Sci; 2011 Nov; 310(1-2):197-201. PubMed ID: 21683375 [TBL] [Abstract][Full Text] [Related]
46. Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management. O'Sullivan SS; Evans AH; Lees AJ CNS Drugs; 2009; 23(2):157-70. PubMed ID: 19173374 [TBL] [Abstract][Full Text] [Related]
47. The high prevalence of impulse control behaviors in patients with early-onset Parkinson's disease: A cross-sectional multicenter study. Vela L; Martínez Castrillo JC; García Ruiz P; Gasca-Salas C; Macías Macías Y; Pérez Fernández E; Ybot I; Lopez Valdés E; Kurtis MM; Posada Rodriguez IJ; Mata M; Ruiz Huete C; Eimil M; Borrue C; Del Val J; López-Manzanares L; Rojo Sebastian A; Marasescu R J Neurol Sci; 2016 Sep; 368():150-4. PubMed ID: 27538621 [TBL] [Abstract][Full Text] [Related]
48. Management of impulse control disorders in Parkinson's disease: Controversies and future approaches. Samuel M; Rodriguez-Oroz M; Antonini A; Brotchie JM; Ray Chaudhuri K; Brown RG; Galpern WR; Nirenberg MJ; Okun MS; Lang AE Mov Disord; 2015 Feb; 30(2):150-9. PubMed ID: 25607799 [TBL] [Abstract][Full Text] [Related]
49. Drug-induced compulsive behaviors: exceptions to the rule. Graham NA; Hammond CJ; Gold MS Mayo Clin Proc; 2009 Sep; 84(9):846-7; author reply 847. PubMed ID: 19720785 [No Abstract] [Full Text] [Related]
50. Impulse control disorders in Chinese Parkinson's disease patients: the effect of ergot derived dopamine agonist. Auyeung M; Tsoi TH; Tang WK; Cheung CM; Lee CN; Li R; Yeung E Parkinsonism Relat Disord; 2011 Sep; 17(8):635-7. PubMed ID: 21705258 [TBL] [Abstract][Full Text] [Related]
51. Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson's disease. Politis M; Loane C; Wu K; O'Sullivan SS; Woodhead Z; Kiferle L; Lawrence AD; Lees AJ; Piccini P Brain; 2013 Feb; 136(Pt 2):400-11. PubMed ID: 23378222 [TBL] [Abstract][Full Text] [Related]
52. [Stealing as an Impulse Control Disorder Associated with Pramipexole - A Case Report from Forensic Psychiatric Practice]. Clemm von Hohenberg C; Dreßing H Psychiatr Prax; 2017 Apr; 44(3):172-174. PubMed ID: 28399600 [TBL] [Abstract][Full Text] [Related]
53. [Impulse control disorders in Parkinson's disease]. Joutsa J; Kaasinen V Duodecim; 2013; 129(22):2351-8. PubMed ID: 24397147 [TBL] [Abstract][Full Text] [Related]
54. Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease. Perez-Lloret S; Rey MV; Fabre N; Ory F; Spampinato U; Brefel-Courbon C; Montastruc JL; Rascol O Clin Neuropharmacol; 2012; 35(6):261-5. PubMed ID: 23123689 [TBL] [Abstract][Full Text] [Related]
55. Non-motor symptom burden in patients with Parkinson's disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort. Jesús S; Labrador-Espinosa MA; Adarmes AD; Méndel-Del Barrio C; Martínez-Castrillo JC; Alonso-Cánovas A; Sánchez Alonso P; Novo-Ponte S; Alonso-Losada MG; López Ariztegui N; Segundo Rodríguez JC; Morales MI; Gastón I; Lacruz Bescos F; Clavero Ibarra P; Kulisevsky J; Pagonabarraga J; Pascual-Sedano B; Martínez-Martín P; Santos-García D; Mir P; Sci Rep; 2020 Oct; 10(1):16893. PubMed ID: 33037247 [TBL] [Abstract][Full Text] [Related]
56. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome]. Bayard S; Cochen De Cock V; Dauvillers Y Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031 [TBL] [Abstract][Full Text] [Related]
57. Impulse Control Disorders in the Polish Population of Patients with Parkinson's Disease. Toś M; Grażyńska A; Antoniuk S; Siuda J Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629758 [No Abstract] [Full Text] [Related]
58. New pharmacological and neuromodulation approaches for impulsive-compulsive behaviors in Parkinson's disease. Grassi G; Albani G; Terenzi F; Razzolini L; Ramat S Neurol Sci; 2021 Jul; 42(7):2673-2682. PubMed ID: 33852081 [TBL] [Abstract][Full Text] [Related]
59. Impulse control and related behaviors in Parkinson's disease with dementia. Martinez-Martin P; Wan YM; Ray Chaudhuri K; Schrag AE; Weintraub D Eur J Neurol; 2020 Jun; 27(6):944-950. PubMed ID: 32048392 [TBL] [Abstract][Full Text] [Related]